- Fee assured
- Verified this account
- Head & neck oncology
Jonathan Hughes graduated from University of Bristol Medical School in 2000. He received training in Plastic Surgery, Neurosurgery and General Surgery prior to starting his Ear, Nose and Throat (ENT) training. His higher surgical training included placements at recognised centres of excellence, including The Royal National Throat, Nose and Ear, Imperial College, University College, and St Bartholomew's Hospitals.
During his ENT training, Jonathan was awarded the Royal College of Surgeons of England Research Fellowship to undertake basic science research into viral gene therapy for the treatment of cancer. This research was conducted at the Barts Cancer Institute and culminated in the award of PhD in 2013.
Following ENT training and research, he completed two Royal College of Surgeons of England accredited fellowships forming the basis for his super-specialist interests. The Imperial College Head and Neck Fellowship focused on management of benign and malignant tumours of the head and neck. The North Thames Laryngology Fellowship was based at the National Centre for Airway Reconstruction at Charing Cross Hospital and focused on management of voice, airway and swallowing problems.
In 2014, Jonathan completed a travelling fellowship to two international centres of excellence in the USA. Memorial Sloan Kettering is the top cancer hospital in the USA and Hospital of the University of Pennsylvania is a pioneering centre for the use of robotic technology in head and neck surgery. During this time he learnt the very latest minimally-invasive techniques used by world leaders in the field of ENT.
In February 2015 he was appointed as a Consultant ENT / Head and Neck Surgeon at University College London Hospitals and Royal Free London NHS Foundation Trusts.
He has published over 30 academic papers and book chapters, and teaches on a number of national and international medical courses.
Areas of interest
General Paediatric ENT including Glue ear, grommets, tonsils and adenoids;
General Adult ENT;
Hearing loss and Tinnitus;
Nasal blockage and Sinus problems, including Endoscopic Sinus Surgery;
Voice and Swallowing problems;
Head and Neck Cancer;
Salivary gland disease;
Parotid and Submandibular gland surgery;
Thyroid and Parathyroid Surgery, including minimal access surgery;
- Kate Davies
- Medical Management Services High Trees Hillfield Road Hemel Hempstead HP2 4AA
- 020 3897 0667
- 07926 402795
- 0844 858 1122
Anaesthetists worked with (Bupa members, please ask your consultant whether your anaesthetist is fee-assured)
Current NHS consultant posts held
Consultant ENT / Head and Neck / Thyroid Surgeon at University College London Hospitals and Royal Free London NHS Foundation Trusts.
Head and Neck Oncology
Molecular Oncology/Gene Therapy
Family, Running, Cycling.
HCA International Foundation Grant 2014
RCS England Colledge Family Memorial Fellowship Fund 2014
RSM Section of Laryngology & Rhinology Research Grant 2011
Barts and The London Charity Cancer Research Fund 2010
Royal College of Surgeons of England Research Fellowship 2009
Barts and The London Charity Clinical Fellowship 2009
Barts and The London Charity Special Purpose Fund 2009
Journal of Laryngology and Otology Research Scholarship 2009
30 academic papers and book chapters
Most recent papers:
1. Factors associated with delays in head and neck cancer treatment: case-control study. Nash R, Hughes J, Sandison A, Stewart S, Clarke P, Mace A. The Journal of Laryngology and Otology. 2015 Apr;129(4):383-5.
2. Isolated Herpes Simplex in the Adult Larynx: A rare complication of methotrexate-induced immunosuppression. J Lee, S Ojha, J Hughes, J Weir. The Journal of Laryngology and Otology. 2015 Jul;129(7):718-20.
3. Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus. Hughes J, Wang P, Alusi G, Shi H, Chu Y, Wang J, Bhakta V, McNeish I, McCart A, Lemoine NR, Wang Y. Gene Therapy. 2015 Jun;22(6):476-84.
4. Viral Gene Therapy for Head and Neck Cancer. J Hughes, G Alusi, Y Wang. The Journal of Laryngology and Otology. 2015 Apr;129(4):314-20.
5. Delayed presentation of a large congenital laryngeal cleft in an adult. M. Bakir, J Hughes, G Sandhu. Annals of Royal College of Surgeons of England. 2015 Jan;97(1):e6-8.
6. A Vaccinia virus armed with interleukin-10 is a promising therapeutic agent for treatment of murine pancreatic cancer. Louisa Chard, Eleni Maniati, Pengju Wang, Jiwei Wang, Fengyu Cao, Jahangir Ahmed, Jonathan Hughes, Margueritte Khouri, Shengdian Wang, Xiaozhu Li, Bela Denes, Istvan Fodor, Thorsten Hagemann, Nicholas Lemoine, and Yaohe Wang. Clinical Cancer Research. 2015 Jan 15;21(2):405-16.
Courses offered to GPs
Head and Neck Oncology
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.https://www.iwantgreatcare.org/doctors/dr-jonathan-hughes
- PhD University of London 2013
- FRCS Royal College of Surgeons of England 2012
- MBChB University of Bristol 2000
- BSc University of Bristol 1997
Details of entry to specialist register
- Completion of Specialist Training, 2013
Affiliations / memberships
Royal College of Surgeons of England
British Laryngological Association
British Association of Head and Neck Oncologists
British Association of Endocrine and Thyroid Surgeons
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.